ca_enviro
2 records
CA Environmental: ALLERGAN — Cleanup Program Site
1990-09-14
FULLERTON, Orange County | Status: Completed - Case Closed | Agency: ORANGE COUNTY LOP
View Source
CA Environmental: ALLERGAN — LUST Cleanup Site
1990-02-14
FULLERTON, Orange County | Status: Completed - Case Closed | Agency: ORANGE COUNTY LOP
View Source
courtlistener_docket
13 records
BESCH v. ALLERGAN, INC
2026-06-02
Federal docket 2:26-cv-06445 (njd); matched party 'ALLERGAN, INC'
View Source
RODRIGEZ v. ALLERGAN, INC
2026-06-01
Federal docket 2:26-cv-06358 (njd); matched party 'ALLERGAN, INC'
View Source
JARCHOW v. ALLERGAN, INC
2026-06-01
Federal docket 2:26-cv-06353 (njd); matched party 'ALLERGAN, INC'
View Source
PATRIZZO-SELZER v. ALLERGAN, INC.
2026-06-01
Federal docket 2:26-cv-06354 (njd); matched party 'ALLERGAN, INC.'
View Source
JARCHOW v. ALLERGAN, INC
2026-05-29
Federal docket 2:26-cv-06289 (njd); matched party 'ALLERGAN, INC'
View Source
GIERKE v. ALLERGAN, INC
2026-05-29
Federal docket 2:26-cv-06264 (njd); matched party 'ALLERGAN, INC'
View Source
KNOBLOCK v. ALLERGAN, INC.
2026-05-13
Federal docket 2:26-cv-05419 (njd); matched party 'ALLERGAN, INC.'
View Source
BUI v. ALLERGAN, INC.
2026-05-13
Federal docket 2:26-cv-05418 (njd); matched party 'ALLERGAN, INC.'
View Source
ALDERMAN v. ALLERGAN, INC.
2026-04-14
Federal docket 2:26-cv-03952 (njd); matched party 'ALLERGAN, INC.'
View Source
MURPHY v. ALLERGAN, INC
2026-03-30
Federal docket 2:26-cv-03362 (njd); matched party 'ALLERGAN, INC'
View Source
KING v. ALLERGAN, INC.
2026-03-27
Federal docket 2:26-cv-03299 (njd); matched party 'ALLERGAN, INC.'
View Source
KING v. ALLERGAN, INC.
2026-03-27
Federal docket 2:26-cv-03298 (njd); matched party 'ALLERGAN, INC.'
View Source
MERRILL v. ALLERGAN, INC.
2026-03-27
Federal docket 2:26-cv-03283 (njd); matched party 'ALLERGAN, INC.'
View Source
Department of Justice
2 records
DOJ: Allergan acepta declararse culpable y pagar $600 millones de dólares para resolver alegatos de promoción de usos no aprobados del Botox®
2022-03-29
WASHINGTON – La empresa farmacéutica estadounidense Allergan Inc. ha aceptado declararse culpable y pagar $600 millones de dólares para resolver su responsabilidad criminal y civil surgida de la promo...
View Source
DOJ: Allergan Agrees to Plead Guilty and Pay $600 Million to Resolve Allegations of Off-Label Promotion of Botox®
2010-09-01
WASHINGTON – American pharmaceutical manufacturer Allergan Inc. has agreed to plead guilty and pay $600 million to resolve its criminal and civil liability arising from the company’s unlawful promotio...
View Source
fda
28 records
FDA Drug Recall: Refresh Relieva PF Preservative-Free Lubricant Eye Drops 0.33 fl oz (10 mL) Ster
2021-01-27
Class II — Labeling: Missing instructions for use insert
View Source
FDA Drug Recall: Skin Medica Acne System, Contains: Purifying Foaming Wash (Salicylic Acid 2.0%),
2020-08-05
Class III — SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.
View Source
FDA Drug Recall: Skin Medica Acne Treatment Lotion (Benzoyl Peroxide 2.5%), 2 Oz bottle, Distribu
2020-08-05
Class III — SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.
View Source
FDA Recall: Allergan PLC — Class I
20190918
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence o | Product: Natrelle, Saline-Filled Breast Implant...
View Source
FDA Recall: Allergan PLC — Class I
20190918
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence o | Product: Natrelle133 Plus Tissue Expander With/...
View Source
FDA Recall: Allergan PLC — Class I
20190918
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence o | Product: Komuro, Soft Touch, BIOCELL, INTRASHIE...
View Source
FDA Device Recall: Natrelle Silicone Filled Breast Implants for the following Styles and Sizes: Sty
2019-12-25
Class III — The firm has became aware that 2D barcodes on breast implants and sizers may be unreadable by GS-1 configured scanners. These 2D barcodes contain a group separators between fixed-length el...
View Source
FDA Device Recall: Natrelle Saline-Filled Breast Implant, for the following Styles and sizes, Style
2019-12-25
Class III — The firm has became aware that 2D barcodes on breast implants and sizers may be unreadable by GS-1 configured scanners. These 2D barcodes contain a group separators between fixed-length el...
View Source
FDA Device Recall: XEN Gel Stent, REF 5513-001(US Model), Sterile, RX Only, (01)10888628032439 ; Ot
2019-12-11
Class II — Residual polishing compounds, that are used in the needle sleeve manufacturing process, may be present on the injector needle. The residual polishing compounds could transfer to the patient...
View Source
FDA Device Recall: Natrelle, Saline-Filled Breast Implant Biocell Full Height with Fill Tube, Steri
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: Natrelle133 Plus Tissue Expander With/Without Suture Tabs, BioCell Full Height V
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: Komuro, Soft Touch, BIOCELL, INTRASHIEL, BioDIMENSIONAL breast implants, Styles
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: Natrelle 150 Full Height and Short Height Implants, BIOCELL, INTRASHIEL, BioDIME
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: Natrelle and McGhan 410 TruForm 2 (Soft Touch) BIOCELL breast implant, Styles LL
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: Natrelle Inspira, Silicone-Filled Breast Implants, Sterile, for the following st
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: Natrelle and McGhan Silicone-Filled Breast Implants, TruForm 2 (Soft Touch), BIO
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: McGhan Croissant-Shaped Tissue Expanders, Style 134 Product Usage: intended f
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: Natrelle and McGhan Silicone-Filled Breast Implant BioCell Round Moderate Profil
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Device Recall: Natrelle 133 Tissue Expanders w/Suture Tabs BIOCELL Full Height Variable Project
2019-09-18
Class I — The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-AL...
View Source
FDA Drug Recall: OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic appli
2019-01-16
Class II — GMP Deviations: A silicone particulate was noted in Ozurdex.
View Source
FDA Drug Recall: INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL), Rx onl
2018-12-05
Class II — Failed Stability Specification: out of specification for iron content.
View Source
FDA Drug Recall: Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's
2018-06-20
Class I — Contraceptive Tablets Out of Sequence.
View Source
FDA Drug Recall: INFeD (Iron Dextran Injection USP) 100 mg elemental iron/2 ml (50 mg/mL), Rx Onl
2018-03-07
Class II — Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.
View Source
FDA Drug Recall: NORCO (Hydrocodone Bitartrate and Acetaminophen) Tablets, USP, 10 mg/325 mg, 100
2018-02-21
Class III — Labeling: Not Elsewhere Classified: does not have the required "CII" controlled drug classification indication on the primary label.
View Source
FDA Drug Recall: Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle, Rx only, Dis
2018-01-17
Class II — Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.
View Source
FDA Device Recall: Natrelle 133 Series Tissue Expanders Product Usage: Natrelle 133 Series Tiss
2015-07-29
Class II — Allergan is recalling the NATRELLE 133 and CUI Series Tissue Expanders because the product shipped was beyond the 47 month shelf life.
View Source
FDA Device Recall: Natrelle CUI Series Tissue Expanders. Product Usage: Natrelle CUI Series Tis
2015-07-29
Class II — Allergan is recalling the NATRELLE 133 and CUI Series Tissue Expanders because the products shipped were beyond the shelf life.
View Source
FDA Device Recall: Natrelle Re-sterilizable Breast Implant Sizer, Size: 410 cc, Style No. MSZFX410.
2015-07-15
Class II — Allergan is recalling the NATRELLE 410cc Re-Sterilizable Breast Implant Sizer because the expired product was shipped to the user level.
View Source
fda_adverse
1 records
FDA AE Manufacturer: Allergan, Inc.
Drug adverse event reporter — Product: DEXAMETHASONE
View Source
ftc_enforcement
4 records
AbbVie Inc. and Allergan plc, In the Matter of
2020-09-04
FTC live enforcement action FY2020; matched respondent 'Allergan plc, In the Matter of'
View Source
Dissenting Statement of Commissioner Rohit Chopra In the Matter of AbbVie Inc. and Allergan plc
2020-05-05
FTC live enforcement action FY2020; matched respondent 'Allergan plc'
View Source
Statement of the Federal Trade Commission In the Matter of Teva Pharmaceuticals Industries Ltd. and Allergan plc
2016-07-27
FTC live enforcement action FY2016; matched respondent 'Allergan plc'
View Source
Allergan, Inc., and Inamed Corporation, In the Matter of
2006-04-21
FTC live enforcement action FY2006; matched respondent 'Allergan, Inc.'
View Source
lobbying
1 records
Lobbying Firm: ALLERGAN, INC.
Registered lobbying firm — IRVINE, CA — DEVELOP, MANUFACTURE, MARKET AND SELL SPECIALTY PHARMACEUTICALS
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.